Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Tatjana S Potpara1,2, Charles J Ferro3, Gregory Y H Lip1,3,4

  • 1School of Medicine, Belgrade University, Belgrade, Serbia.

Insights

Atrial fibrillation (AF) and chronic kidney disease (CKD) share risk factors and worsen each other. Non-vitamin K antagonist oral anticoagulants (NOACs) are effective for mild-to-moderate CKD, but management for severe CKD remains challenging.

Area of Science:

  • Cardiology
  • Nephrology

Background:

  • Atrial fibrillation (AF) and chronic kidney disease (CKD) are common and interconnected conditions.
  • Shared risk factors include older age, hypertension, and diabetes mellitus.
  • CKD increases AF risk, while AF can lead to CKD development or progression.

Purpose of the Study:

  • To review the efficacy and safety of anticoagulants in patients with AF and CKD.
  • To highlight the challenges in managing patients with AF and severe CKD or end-stage renal disease on dialysis.

Main Methods:

  • Analysis of data from randomized clinical trials comparing NOACs and warfarin in AF patients with varying degrees of CKD.
  • Review of observational cohort studies concerning anticoagulation in advanced CKD.

Main Results:

  • NOACs demonstrated similar efficacy and safety to warfarin in AF patients with mild-to-moderate CKD, requiring dose adjustments.
  • Evidence for managing AF patients with severe CKD or on dialysis is limited, with conflicting results from observational studies.
  • Patients with advanced CKD have increased thromboembolic and bleeding risks.

Conclusions:

  • NOACs are a viable option for AF patients with mild-to-moderate CKD when dosed appropriately.
  • Management of AF in severe CKD or end-stage renal disease necessitates careful risk-benefit assessment, potentially involving warfarin with close monitoring.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Oral Cavity01:11

Oral Cavity

The oral cavity, or the mouth, is a complex structure in humans that plays a vital role in our day-to-day lives. Its role is not only in chewing and swallowing food; it also plays a role in speech and facial expressions.
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
3.2K